Knee osteoarthritis drug trial halted early – what we know
NCT ID NCT04864392
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called LNA043, given as injections into the knee, to see if it could slow cartilage loss and reduce pain in people with knee osteoarthritis. The trial planned to follow 576 participants for up to 5 years, but it was terminated early. The main goal was to measure changes in cartilage thickness using MRI.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LNA043 (an experimental drug injected into the knee joint)
What this could lead to
If successful, this could point toward a treatment that slows cartilage loss and eases pain in knee osteoarthritis.
What could go wrong
The trial was terminated early, so results are limited. It is still experimental and may not prove effective or safe in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMR Knoxville
Knoxville, Tennessee, 37920, United States
-
Annapolis Rheumatology LLC
Fairfax, Virginia, 22033, United States
-
Artemis Institute Clinical Research
Riverside, California, 92503, United States
-
Arthemis Clinical Research
San Diego, California, 92103, United States
-
Center For Pharmaceutical Research
Kansas City, Missouri, 64114, United States
-
Charlottesville Medical Research
Charlottesville, Virginia, 22911, United States
-
Chicago Clinical Research Inst
Chicago, Illinois, 60607, United States
-
Clinical Research of West Florida Inc
Tampa, Florida, 33603, United States
-
Clinical Trials Research
Lincoln, California, 95648, United States
-
Conquest Research
Winter Park, Florida, 32789, United States
-
Drug Trials America
Hartsdale, New York, 10530, United States
-
Elite Clinical Studies
Phoenix, Arizona, 85018, United States
-
Long Beach Clinical Trials
Long Beach, California, 90806, United States
-
Metroplex Clinical Research
Dallas, Texas, 75231, United States
-
Northern California Research
Sacramento, California, 95821, United States
-
Novartis Investigative Site
Caba, C1428AZF, Argentina
-
Novartis Investigative Site
Córdoba, X5000EOC, Argentina
-
Novartis Investigative Site
San Miguel de Tucumán, 4000, Argentina
-
Novartis Investigative Site
Broadmeadow, New South Wales, 2292, Australia
-
Novartis Investigative Site
Maroochydore, Queensland, 4558, Australia
-
Novartis Investigative Site
Woodville South, South Australia, 5011, Australia
-
Novartis Investigative Site
Hobart, Tasmania, 7000, Australia
-
Novartis Investigative Site
Malvern East, Victoria, 3145, Australia
-
Novartis Investigative Site
Christchurch, 8011, Australia
-
Novartis Investigative Site
St Leonards, 2065, Australia
-
Novartis Investigative Site
Waikanae Beach, 5036, Australia
-
Novartis Investigative Site
Québec, Quebec, G1V 3M7, Canada
-
Novartis Investigative Site
Trois-Rivières, Quebec, G9A 3Y2, Canada
-
Novartis Investigative Site
Beijing, Beijing Municipality, 100044, China
-
Novartis Investigative Site
Bengbu, 233004, China
-
Novartis Investigative Site
Brno, Czech Republic, 66250, Czechia
-
Novartis Investigative Site
Pardubice, Czech Republic, 530 02, Czechia
-
Novartis Investigative Site
Brno-Zidonice, CZE, 61500, Czechia
-
Novartis Investigative Site
Brno, 638 00, Czechia
-
Novartis Investigative Site
Uherské Hradiště, 686 01, Czechia
-
Novartis Investigative Site
Aarhus N, 8200, Denmark
-
Novartis Investigative Site
Gandrup, 9362, Denmark
-
Novartis Investigative Site
Vejle, 7100, Denmark
-
Novartis Investigative Site
Tallinn, 10128, Estonia
-
Novartis Investigative Site
Tartu, 50708, Estonia
-
Novartis Investigative Site
Vadodara, Gujarat, 390022, India
-
Novartis Investigative Site
Belagavi, Karnataka, 590010, India
-
Novartis Investigative Site
Lucknow, Uttar Pradesh, 226003, India
-
Novartis Investigative Site
Pune, 411019, India
-
Novartis Investigative Site
Shinagawa, Tokyo, 140 0014, Japan
-
Novartis Investigative Site
Shinjuku Ku, Tokyo, 160-0008, Japan
-
Novartis Investigative Site
Suginami, Tokyo, 166-0002, Japan
-
Novartis Investigative Site
Chuoh-ku, 104-0031, Japan
-
Novartis Investigative Site
Osaka, 543-0027, Japan
-
Novartis Investigative Site
Guadalajara, Jalisco, 44650, Mexico
-
Novartis Investigative Site
Culiacán, Sinaloa, 80000, Mexico
-
Novartis Investigative Site
Ciudad de, CP 06700, Mexico
-
Novartis Investigative Site
Kielce, 25-017, Poland
-
Novartis Investigative Site
Krakow, 31-501, Poland
-
Novartis Investigative Site
Poznan, 60-446, Poland
-
Novartis Investigative Site
Warsaw, 02-677, Poland
-
Novartis Investigative Site
Santiago, A Coruna, 15705, Spain
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Barcelona, Catalonia, 08003, Spain
-
Novartis Investigative Site
A Coruña, 15006, Spain
-
Novartis Investigative Site
Madrid, 28046, Spain
-
Novartis Investigative Site
Seville, 41010, Spain
-
Novartis Investigative Site
Changhua, 50006, Taiwan
-
Novartis Investigative Site
Tainan, 704302, Taiwan
-
Novartis Investigative Site
Glasgow, Scotland, G51 4TF, United Kingdom
-
Novartis Investigative Site
Barnet, EN5 3DJ, United Kingdom
-
Novartis Investigative Site
Norwich, NR4 7UY, United Kingdom
-
Pioneer Research Solutions
Sugar Land, Texas, 77479, United States
-
Sensible Healthcare
Ocoee, Florida, 34761, United States
-
Sharps Hospital Grossmont
La Mesa, California, 91942, United States
-
Stamford Therapeutics Consortium LLC
Stamford, Connecticut, 06905, United States
-
Tandem clinical research
Marrero, Louisiana, 70072, United States
-
The Center for Rheumatology and Bone Research
Wheaton, Maryland, 20902, United States
-
Tucson Orthopedic Institute PC
Tucson, Arizona, 85712, United States
-
Virginia Ispine Physicians PC
Richmond, Virginia, 23238, United States